Screening for antibodies against the EJ antigen is performed in patients with possible polymyositis, dermatomyositis, and overlap syndrome.
EJ antibodies can be detected in < 5% of patients with inflammatory myositis (polymyositis/dermatomyositis). The EJ antigen corresponds to the glycyl-tRNA-synthase enzyme.